Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Regenerative Medicine

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1765259

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1765259

Stromal Vascular Fraction

PUBLISHED:
PAGES: 214 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Stromal Vascular Fraction Market to Reach US$127.8 Million by 2030

The global market for Stromal Vascular Fraction estimated at US$98.2 Million in the year 2024, is expected to reach US$127.8 Million by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Isolation Products, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$99.5 Million by the end of the analysis period. Growth in the Aspiration Products segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$32.3 Million While China is Forecast to Grow at 5.6% CAGR

The Stromal Vascular Fraction market in the U.S. is estimated at US$32.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$9.7 Million by the year 2030 trailing a CAGR of 5.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Stromal Vascular Fraction Market - Key Trends and Drivers Summarized

Stromal Vascular Fraction (SVF) is a diverse cell population derived from adipose (fat) tissue, which is harvested through liposuction procedures. SVF contains a rich mix of several cell types including adipose-derived stem cells (ADSCs), endothelial (blood vessel) cells, immune cells, and other cellular components. This cell mixture is particularly noted for its regenerative properties, making it a promising tool in regenerative medicine and tissue engineering. The process of isolating SVF involves enzymatic digestion of adipose tissue followed by centrifugation to separate the cellular fraction from adipocytes (fat cells). SVF is currently being explored in a variety of therapeutic applications ranging from cosmetic procedures enhancing soft tissue repair to more complex clinical scenarios like treating chronic wounds, osteoarthritis, and cardiovascular diseases.

The potential of SVF in clinical therapies is vast due to its minimally invasive extraction process and the regenerative capabilities of the cells it contains. Research in SVF has expanded significantly, showing promising results in enhancing healing processes and reducing inflammation. The autologous nature of SVF (derived from the patient’s own body) minimizes the risk of rejection and adverse immune reactions, a significant advantage over other transplantable materials. Recent advancements in the field have aimed at refining the isolation techniques to increase the yield and viability of cells in SVF, and enhancing the understanding of the specific roles of different cell types within the fraction. These improvements are critical in maximizing the therapeutic potential of SVF in regenerative medicine, making it a key area of ongoing scientific research.

The growth in the SVF market is driven by several factors, including advancements in cell isolation technologies and a deepening understanding of regenerative medicine. Increased investment in biotechnology research has propelled the development of more efficient and scalable processing techniques, which are crucial for the wider adoption of SVF-based therapies. Additionally, the growing demand for minimally invasive cosmetic and therapeutic procedures has significantly contributed to the popularity of SVF. The demand for aesthetic & reconstructive therapies continues to grow owing to the never-ending desire of people to look younger and retain youthful appearance, while creating ample opportunities for related markets such as stromal vascular fraction (SVF) treatment method. Regulatory frameworks are also evolving to better accommodate the clinical use of such innovative therapies, thereby encouraging more clinical trials and applications. Moreover, as the general population ages, there is an increasing prevalence of degenerative diseases which can potentially be treated with SVF, thus expanding the target demographic. Together, these elements are key drivers promoting the sustained growth and development of the SVF sector in the biomedical field.

SCOPE OF STUDY:

The report analyzes the Stromal Vascular Fraction market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Isolation Products, Aspiration Products, Transfer Products); Application (Soft Tissue, Cosmetic, Orthopedic, Other Applications); End-Use (Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 25 Featured) -

  • GE HealthCare PLC
  • Kyocera Corporation
  • Stempeutics Research Pvt., Ltd.
  • Genesis Biosystems, Inc.
  • IntelliCell BioSciences, Inc.
  • human med AG
  • InGeneron, Inc.
  • iXCells Biotechnologies
  • Jointechlabs, Inc.
  • Froceth
  • GID BIO
  • Obatala Sciences

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP15044

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Stromal Vascular Fraction - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Stem Cells, Application Areas, and the Different Types: A Prelude
    • Applications of Stem Cells
    • Types of Stem Cells
    • Stromal Vascular Fraction: An Introduction
    • Production Method for SVF
    • SVF Cell Procedure
    • SVF Composition, Content, and Source
    • SVF: Mechanism of Action
    • SVF: Clinical Applications
    • Safety and Efficiency of SVF
    • Clinical Trials and Regulations Related to SVF
    • Limitations and Scope
  • GLOBAL MARKET OVERVIEW
    • Extensive Therapeutic Scope Set to Stimulate Growth of Global Stromal Vascular Fraction Market
    • Soft Tissue Segment Leads the Market
    • North America Dominates the Global Market, Asia-Pacific to Witness Fastest Growth
    • Lucrative Opportunities & Restraints
    • Market Restraints
    • Salient Drivers Offering Growth Impetus to Stromal Vascular Fraction Market
    • Extensive Application Scope
    • Rising Focus on Non-Enzymatic Isolation Techniques
    • Strong Research Focus on Optimization of Tissue Recovery
    • Consistent Efforts to Develop Better Cell Therapies
    • Competition
    • Players Bet on Product Innovation to Push Footprint in Stromal Vascular Fraction Market
    • Recent Market Activity
    • SVF Isolation Products Continue to Make Gains
  • PIPELINE ANALYSIS
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Regenerative Medicine: A Promising Application of Stromal Vascular Fraction
    • Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025
    • Increased Prevalence of Musculoskeletal Disorders & Knee Osteoarthritis Steers Market Expansion
    • Use of SVF in Osteoarthritis Treatment
    • Surging Demand for Aesthetic & Reconstructive Therapies Enhances Market Prospects
    • Increasing Awareness about Stem Cell Therapy Augurs Well
    • Innovative Methods Become Relevant in Optimizing Tissue Recovery
    • Stromal Vascular Formation Holds Significance for Chronic Diseases
    • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • Stromal Vascular Fraction in Diabetic Care
    • Rising Diabetes Prevalence Presents Opportunity for iPSCs Market: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
    • Low Temperature Settings Optimize Vitality of Adipose Tissue-derived SVFs
    • SVF Offers Helpful Microenvironment to Regulate ASC Activity under Specific Clinical Conditions
    • Swift Influx of Stem Cell Therapies Requires Alternate Regulatory Pathway Covering Autologous SVF
    • The Counterview
    • Contrast with Regulatory Framework Covering HCT/Ps
    • Aging Demographics Add to the Global Burden of Chronic Diseases, Presenting Opportunities for Stromal Vascular Fracture
    • Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
    • High Incidence of Neurological Disorders: A Key Market Driver
    • Annual Incidence of Adult-Onset Neurologic Disorders in the US
    • Diagnosed Prevalence Cases of Parkinson's Disease Across Select Countries
    • Increase in Healthcare Spending Stirs Demand for Stromal Vascular Formation
    • Expansion of Private Hospitals in Rural Areas
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Isolation Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Isolation Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Aspiration Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Aspiration Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Transfer Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Transfer Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Soft Tissue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Soft Tissue by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Cosmetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Cosmetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Orthopedic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World 6-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Stem Cell Banks/Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World 6-Year Perspective for Stem Cell Banks/Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 22: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 23: World Stromal Vascular Fraction Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Stromal Vascular Fraction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • JAPAN
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • CHINA
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • EUROPE
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Stromal Vascular Fraction by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • FRANCE
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • GERMANY
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • UNITED KINGDOM
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!